QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing
Go back to QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing| Qiagen NV (NYSE: QGEN) | Delayed: 36.28 -0.67 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.95 | 52 Week High | $28.50 | |||
| Open | $36.74 | 52 Week Low | $19.94 | |||
| Day High | $36.94 | P/E | 125.10 | |||
| Day Low | $36.28 | EPS | $0.29 | |||
| Volume | 2,624,822 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
